The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
112 - As a private clinic we are planning to prepare advertising material to be played on TV only to the patients waiting in the waiting area. The contents of these ads will be prepared by specialists in different medical disciplines. This will mostly contain OTC, NHP products. Is this activity subject to PAAB review?
FYI post-approval change/preclearance exemption/what requires review/PAAB scope
1
Posts
1
Posters
303
Views
1
Watching
-
Advertising displayed in the waiting room would be considered direct to consumer advertising. Direct to consumer advertising of OTC and NHP products fall within the jurisdiction of Ad Standards Canada. We suggest contacting Ad Standards at 416-961-6311 (http://www.adstandards.com/en/). Note, however, that patient information for an OTC or NHP product involving the health care professional as an intermediary would require PAAB review under code section 6. The PAAB provides advisory comments on vaccine and prescription direct-to-consumer advertising or information materials.
